Tonix Pharmaceuticals CEO Seth Lederman acquires $20,275 in common shares

TNXP•2026-11-12

CEO and director Seth Lederman purchased 5,000 Tonix Pharmaceuticals shares at $4.055 each, bringing his direct holdings to 16,005 shares and indirect holdings to 20,002 shares.

Tonix Pharmaceuticals CEO Seth Lederman acquires $20,275 in common shares

1. Share purchase

Related News

Evaxion publishes update to financial calendar

AIM ImmunoTech CEO Thomas K. Equels reports acquiring $5,382 in shares

Komatsu agrees to acquire Astec's road construction equipment business

Sources

Tonix Pharmaceuticals CEO Seth Lederman acquires $20,275 in common shares

BTCS Q3 2026 net income swings to $54.5 million from Q2 loss

HUHUTECH receives grant notices for two gas handling equipment patents